Treatment Options for Multinucleate Cell Angiohistiocytoma: A Case Series and Review of the Literature.
Ana TaiboCristina Prego PadinJesus Del Pozo LosadaEduardo FonsecaPublished in: Journal of cutaneous medicine and surgery (2023)
We propose PDL therapy as a first-line treatment for MCAH since it achieves satisfactory esthetic results, while being well-tolerated. Selecting those amenable patients according to morphologic characteristics may be useful to avoid unsuccessful therapies. In MCAH with predominant fibrous stroma, surgery or CO2 laser may be the best option.